USPTO trademark

CAVTHYSTA

RegisteredUSPTOWord markClass 5

"CAVTHYSTA" is a word mark owned by AstraZeneca AB, filed at the USPTO on August 29, 2022. It is registered and covers class 5 (Pharmaceuticals).

View AstraZeneca AB portfolioGet this data via the API
Official USPTO record
CAVTHYSTA trademark as filed
As filed with the USPTO
Status
Registered
Since May 5, 2026
Filed
August 29, 2022
Registered
May 5, 2026
Priority date
June 17, 2022
Claimed from European Union
Application no.
97569457
Registration no.
8237952
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
1 class
Ownership

Who owns CAVTHYSTA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

AstraZeneca AB

Södertälje, Sweden

6,118 trademarks in the portfolioView company

Representative

Cara M. Kearney

Astrazeneca Pharmaceuticals LP

Goods and services

What the mark covers

The products and services CAVTHYSTA is filed for, grouped by Nice class.

  • Pharmaceutical preparations and substances for use in oncology; Pharmaceutical preparations and substances for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, neurological, gastrointestinal and immune systems; Pharmaceutical preparations and substances for the treatment of infection, inflammation, hematological, autoimmune related diseases and disorders; Pharmaceutical preparations and substances, namely, antibodies; vaccines

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Reinstatement granted - request to delete 1(b) filed
  7. Assigned to petition staff
  8. Teas request for reinstatement
  9. Abandonment notice e-mailed - no use statement filed
  10. Abandonment - no use statement filed

10 earlier steps on the official record.

FAQ

About CAVTHYSTA

Who owns the trademark "CAVTHYSTA"?

The USPTO trademark "CAVTHYSTA" (application 97569457) is owned by AstraZeneca AB.

What is the status of "CAVTHYSTA"?

Its status at the USPTO is: registered.

When was "CAVTHYSTA" registered?

It was registered on May 5, 2026.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CAVTHYSTA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019d2ae5-dda5-70ed-9920-ebda4873dfd8
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2ae5-dda5-70ed-9920-ebda4873dfd8",
  "object": "trademark",
  "mark_text": "CAVTHYSTA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97569457",
  "filing_date": "2022-08-29",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "AstraZeneca AB",
      "entity_id": "ent_019eb700-571d-718e-bf3d-80fe37712629"
    }
  ]
}